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Wolfram syndrome (WS) is a rare dysmorphogenetic
recessive disorder characterized by early-onset, nonautoimmune diabetes mellitus (DM), progressive optic
atrophy and further neurological and endocrinological
abnormalities. It was identified in 4 patients in 1938 by
an American physician, DJ Wolfram (1-3). Its prevalence
is reported as 1/770,000-1/100,000 (2-5). DM and optic
atrophy are requisites for diagnosis. Signs that are most
frequently associated with the syndrome are diabetes
insipidus (DI), sensorineural deafness, urinary system
anomalies, ataxia, peripheral neuropathy, mental
retardation and psychiatric problems (3,4).
WS has been attributed to mutations in the WFS1
gene, which codes for a protein predicted to possess 910 transmembrane segments. Little is known concerning
the function of the WFS1 protein (wolframin).
Endoglycosidase H digestion, immunocytochemistry, and
subcellular fractionation studies all indicate that
wolframin is localized to the endoplasmic reticulum in rat
brain hippocampus and rat pancreatic islet beta-cells, and
after ectopic expression in Xenopus oocytes. Expression
of wolframin also increased cytosolic calcium levels in
oocytes. Wolframin thus appears to be important in the
regulation of intracellular Ca2+ homeostasis. Disruption
of this function may place cells at risk of inappropriate
death decisions, thus accounting for the progressive betacell loss and neuronal degeneration associated with the
disease.

Peripheral neuropathy and neurogenic bladder in WS
may result from this mechanism as well as increased
polyol activity (5).
Peculiar findings (hydronephrosis, neurogenic
bladder, short stature, anemia and depression) in 3
patients, 2 of whom were brothers, diagnosed with WS
are presented. The aim of the present report is to alert
physicians about the association between DM and
monogenic syndromes, such as WS, and to address the
necessity of monitoring these patients in terms of
multifaceted problems.

Case Reports
Case 1
An 11-year-old male patient who presented with poor
metabolic control was being followed for DM diagnosed
at 5 years of age, DI and bilateral sensorineural lack of
hearing diagnosed at 8 years of age and depression
diagnosed 1 month previously. His parents were seconddegree cousins and his 8-year-old brother was also being
monitored due to WS diagnosis. The patient was regularly
using insulin and vasopressin. Physical examination of the
patient showed introversion, pallor, short stature (height:
110 cm, below the 3 third percentile), optic atrophy
(Figure 1), bilateral sensorineural hearing loss and truncal
ataxia. Laboratory analyses demonstrated that Hb was
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Figure 1. Optic disk examination of patient 1 showed bilateral optic atrophy.

11.1 g/dl, HbA1c was 12% and fasting blood sugar was
346 mg/dl. It was also found that the patient’s basal and
stimulated growth hormone levels were low (basal
growth hormone: 3 ng/ml, L-Dopa, clonidine-stimulated
growth hormone: 3.2 ng/ml, 3.6 ng/ml hypophysealorigin growth hormone deficiency). Wide-scan metabolic
tests were normal. Repeated audiological examination
revealed that the patient had sensorineural hearing loss at
medium-high frequencies. Bilateral grade 1-2
hydronephrosis was observed in renal ultrasonography
and cerebral and hypophyseal magnetic resonance
imaging (MRI) showed cerebellar atrophy as well as signal
loss in neuro-hypophysis (Figures 2a, b). An antipsychotic
agent (risperidone) was added to the systemic follow-up
and treatment of the patient.
Case 2
The patient, who was the brother of patient 1, was
found to have DM and bilateral optic atrophy at 6 years
of age and DI and bilateral sensorineural hearing loss at
7. He was being treated for these conditions (crystallized
insulin and vasopressin) and his blood sugars were in the
targeted limit during follow-up. His physical examination
showed, in addition to the above-mentioned findings, that
his gait was wide-based and lurching, and that he had
explosive speech. HbA1c was 7.1% and fasting blood
sugar was 102 mg/dl in the laboratory tests and other
findings were normal. Renal ultrasonography showed
bilateral grade 2 hydronephrosis and cerebral MRI
demonstrated cerebellar atrophy.
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Case 3
A 14-year-old girl, who had bilateral sensorineural
loss of hearing at age 9, bilateral optic atrophy at 11 and
DI at 12 came for routine checks. She complained of
recent urinary frequency. Her mother and father were
second-degree relatives and her 3 sisters and 2 brothers
were healthy. In addition to previous findings, short
stature was determined at physical examination (height:
140 cm, below the 3 third percentile). Laboratory tests
showed HbA1c at 8.4% and fasting blood sugar at 128
mg/dl. Her basal and stimulated growth hormone levels
were low (basal growth hormone: 4 ng/ml, L-Dopa,
clonidine-stimulated growth hormone: 4.9 ng/ml, 5.1
ng/ml. hypophyseal-origin growth hormone deficiency).
Urologic examination revealed that she had neurogenic
bladder and treatment was started for this condition. Her
cerebral MRI was normal.
Clinical characteristics of all 3 patients are presented
in the Table.
More than 20 syndromes including WS among the
significant and increasing number of degenerative
diseases of neuronal tissues are known to be associated
with DM. WS is highly variable in its clinical
manifestations, which include DI, DM, optic atrophy, and
deafness. It may affect the central nervous system,
peripheral nerves, and neuroendocrine tissues (5,6). WS
mutations are spread over the entire coding region, and
are typically inactivating, suggesting that a loss of
function causes the disease phenotype. It is established
that WS is a mitochondrial disease, inherited as an
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(A)

(B)
Figure 2. T2 W magnetic resonance imaging showed cerebellar atrophy (A) as well as signal loss
in neuro-hypophysis (B).
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Table. Clinical characteristics of all patients.
Age / DM* / DI* / OA* /
Case

Deafness* (years)

Sex

Relatives

1

11 / 5 / 8 / 10 / 8

M

2

8/6/7/6/7

3

14 / 8 / 12 / 11 / 9

M: Male F: Female
* Diagnosed age

Renal anomalies

Brain MRI

Other findings

+

Bilateral hydronephrosis

Cerebellar atrophy
Signal loss in neurohypophysis

Depression Anemia
(Megaloblastic)
Short stature

F

+

Bilateral hydronephrosis

Cerebellar atrophy

-

F

+

Neurogenic bladder

-

Short stature

DM: Diabetes mellitus

DI: Diabetes Insipidus

autosomal recessive trait and the gene responsible for the
disease is located on the shorter branch of 4p16.1 (6, 7).
A new locus for WS has been located on 4q22-24,
providing evidence for the genetic heterogeneity of this
syndrome.The hypothesis that heterozygous carriers of
the gene for WS are predisposed to psychiatric illness was
supported previously by the finding of an excess of
psychiatric hospitalizations and suicides in WS blood
relatives compared to spouse controls (9).
DM is generally the first symptom in WS and it is
reported that DM develops in the second half of the first
decade and optic atrophy develops in the second half of
the second decade. WS patients may also have DI, loss of
hearing, urinary tract dilatation, ataxia, peripheral
neuropathy, mental retardation, brain stem/cerebral/
cerebellar/olivopontal atrophy, color blindness, vertigo,
anosmia and psychiatric illness (10-12). It is reported in
the literature that all signs, except for DM, DI and optic
atrophy, are seen between 16 and 30 years of age on
average (2,3). Optic atrophy, loss of hearing and renal
anomalies found in all 3 patients developed much earlier
than the ages reported in the literature, and pathological
cerebellar findings in the brothers also developed at a
much lower age than the mean age in the literature
(mean age 30 years, 8 and 11 years in our patients). This
suggests that the emergence of the components of WS
may be influenced by environmental and hereditary
factors, in addition to controlled follow-up of the disease.
Short stature is a common feature in WS. Several
types of hormonal abnormalities are associated with it,
including a deficiency in the somatotropic axis. Induction
of early and adequate hormonal substitution requires
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OA: Optic Atrophy

MRI: Magnetic Resonance Imaging

endocrinological diagnosis. The short stature determined
in patients 1 and 3 may essentially be due to
hypophyseal-origin growth hormone deficiency.
Neurogenic bladder in children with WS can result from
sphincteric dyssynergia, from bladder hyper-reflexia, from
autonomic nerve dysfunction or from a combination of
factors. Dilatation of the urinary tract was considered to
be either a consequence of high diuresis associated with DI
or a degenerative process affecting the central and
peripheral nervous system (3). Since all 3 patients have
urinary tract problems, they need to be closely monitored.
Optic atrophy in case 2 was determined concurrently
with DM. This indicates that optic atrophy in WS can
emerge as early as DM. Another important finding in our
cases was the depression that our first patient had been
experiencing for 1 month. It is reported that depression
may be one of the primary signs of WS and that WS
patients can have a variety of psychiatric problems
(5,9,13). The genetic mutation (4p16.1) responsible for
WS and the capacity of this mutation to create a
disposition towards psychiatric disorders in heterozygote
carriers are well known (9). It has been suggested that
there is a relation between cerebellar atrophy and bipolar
disorders (14). Early manifestation of depression in our
patient may be accounted for by the chronic disease
process, as well as cerebellar involvement.
Parents and siblings of WS patients should be
examined in terms of pathological findings; problems that
tend to become chronic should be noticed early and
specific follow-up/treatment of these should be started as
early as possible. In this way, patients’ quality of life can
be improved and their lifespans can be prolonged.
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